Author: admin

Hospital Carlos III in the travelers unit has been an increase of 182% of patients over five years.

el Carlos III Hospital registers in the traveler’s unit increased by 182% of patients in five years.

This hospital is the only Center that offers comprehensive care before and after the trip to adults and children.

-attention citizens returning from a trip to tropical diseases is increased by 39%

-the hospital administered 18.186 vaccinations 6.420 people who visited abroad in 2009

Madrid, August 2010.- the Minister of health, Javier Fernández-Lasquetty, visited section of Tropical Medicine and Traveler of the Hospital Carlos IIICentre hospital on the public network or risk of the community of Madrid, which offers citizens a comprehensive care both before and after trips to exotic areas. In addition, also has the only unit child traveler, offering vaccination and tips for traveling abroad with children under age.

During the visit, the Adviser presented a balance with data from patients treated in recent years. Fernández-Lasquetty stressed the remarkable increase experienced in the last five years consultations in the unit of the traveler, with a 182% increase, having gone from 2,273 persons benefiting from 2005 to 2009 6.420, and from a single check five years ago to four consultations today, one in afternoon.

Also, Advisor highlighted registered growth of consultations trip are addressed in the unit of Tropical Medicine in the service of infectious diseases. These patients have also experienced a remarkable increase in the past five years, with an increase of 39 per cent, having become of 2.995 in 2005 4.168 in 2009.

To avoid contracting diseases in high-risk areas, physicians of the Hospital Carlos III recommended travelers prepare their displacement in advance and at least one month before departure to attend consultations of advice, where they will receive higiénico-sanitarios tips and relevant vaccine, always referred to by specialists and in a personalized way.

To facilitate access to these consultations was launched in 2007 a web service of summons and general information to Charles III became the first hospital of Spain with quote on-line for one of their specialties. This service can be accessed from the site www.madrid.org . Since its inception has managed 1,780 appointments and has received 1.734.724 visitors.

The increase in consultations of the units of Tropical Medicine and traveler is due especially to the multiplication of travel to exotic areas. In total, last year administered 18.186 doses of vaccines 6.420 people who visited abroad, with an average of three vaccines by patient, especially for hepatitis A with 4.269 vaccines; fever and typhoid 3.364 dose yellow 2.943.

In addition, it should be noted that 76 per cent of travellers recommended preventive treatment for malaria or malaria.

On the destinations most demanded by the travelers who pass by Charles III, Africa stand out with 37%, followed by Asia with 34%, and Latin America with a 27%. By countries, in 2009 the destination star was India, followed by Kenya and Peru. The main reason for travel is tourism, which represents 48% of cases. The reasons for labour represent 15% of cases and those of cooperation, 12%.

Diseases to the back of the trip

The return of the trip is inspection of medicine Tropical of the Carlos III which undertakes to meet the people who have contracted some disease or have trouble. The Centre has studied 5.518 cases of patients in the last five years. The profile of the patient is a woman, 54% of cases, with a median age of 37, has made evil the treatment prescribed, has not paid attention to the health and hygiene measures recommended by the specialists or who has not previously consulted in the unity of the traveller.

Within the Group of patients who presented pathologies on the return of an exotic area and attended consultations of tropical diseases, 37.6 per cent of them traveled by tourism. Secondly, 33% did so for humanitarian reasons, a rate much higher than the of those attending for this reason the unity of the traveller. While 16% were offset by labour.

In the relavito to the places of travel highlights, as well as in the unity of the traveler, Africa, destination of 50% of the aided; second is positioned the American continent, especially South America, target of 30 per cent of the cases. And third place is held by Asia, preferred to 17% of travellers, and with special relevance Southeast Asia.

The results obtained in this study show that the most common pathologies are those related to the digestive system, 21,18% of cases; with febrile processes, 19.28%; and with diseases related to the skin, 17% of patients.

Fever by insect bite

Among patients who came to query to find with a fever chart, 258 cases of malaria or malaria, a disease which can be fatal if left untreated in time have been detected. Also note the 89 cases of dengue fever, Rickettsiosis 83 or 13 identified cases of Chikungunya virus. All of these diseases are transmitted by insect bites and manifested with fever and other symptoms such as joint pain or delirium, depending on the pathology and the degree of affectation.

Travellers with some sort of gastrointestinal pathology usually acquired parasites by swallowing any crude or badly cooked food or liquids without bottle. These parasites often cause diarrhea, nausea and abdominal spasms. And dermatological processes tend to be related to reactions to insect bites, infections by bacteria and fungi, or diseases caused by parasites, such as 125 patients with Larva migrans Cutanea, which is a linear and serpiginoso character dermic eruption produced by larvae of parasites that are introduced under the skin.

Read More

Sixth campaign health Ecuador 2010 of the Spanish society of foreign doctors.

sixth campaign health Ecuador 2010 of the society Spanish of doctors foreigners.

Barcelona, August 2010.- the Spanish society of physicians foreigners (SEMEX) announces that your cooperation AISE (International Association of health in Spain) area manager between September 15 and October 30, 2010, develop the “ sixth campaign health Ecuador 2010 ” in marginal rural and urban areas of the country.

The aim is to promote community development activities, basic health care with special dedication to pediatric health and women and tropical medicine. In addition, carried out tasks of population de-worming, screening for diseases Chronicles (diabetes, hypertension, etc) and training of local medical personnel. At the same time will be delivery of medications and provide health education talks.
The sixth campaign form 2 working groups working group 1, Canton in good faith and the area of the Manga del Cura (province of rivers). The second group being the cantons Valencia, Mocache and Quevedo (province of Los Ríos) and El Carmen and Chone (province of Manabí) cantons.

Locally, this campaign has the support of the corresponding cantonal, municipal governments Ecuador Red Cross and foundations “ Daniel Arroyo ” and “ for you Jesus ”. In Spain the campaign is supported by the “ Foundation starts ” and “ photographers humanitarian ”.

This campaign includes the participation of a contingent of 20 volunteers and will be approximately about 300 kg. medicines.

Spanish society of physicians foreigners

SEMEX is a scientific society non-profit created to promote scientific development and social cohesion of the foreign doctors who live in Spain or those wishing to settle here.

SEMEX aims to provide support and help with all the difficulties that a foreign professional can be found in our environment such as the approval of the title/degree or specialist and the search for better employment opportunities.

On the other hand, SEMEX promotes the participation of foreign doctors in scientific activities, continuing medical education and international collaboration projects.

Read More

National and international experts analysed in “Malaria day workshop” key in the fight against malaria.

National and international experts analysed in “Malaria day workshop” key in the fight against malaria.

Reduce mortality and morbidity and interrupting the transmission of malaria, double aim of current research.

-The eradication of malaria depends largely on the development of new drugs to treat it, as well as new tools to break the cycle of the causative parasite of this disease.

-To get a new generation of drugs we need to make progress in the research of malaria, which can only be achieved with the collaboration between private companies and public entities.

 to right: doctors TIM WELLS, Director of Medicines for Malaria Venture (MMV); NICK CAMMACK, Director of the Campus for the development of drugs for diseases in countries in development (DDW) and PEDRO ALONSO, Director of the Centre for research in international health from Barcelona (CRESIB). Malaria Workshop

to right: doctors TIM WELLS, Director of Medicines for Malaria Venture (MMV); NICK CAMMACK, Director of the Campus for the development of drugs for diseases in countries in development (DDW) and PEDRO ALONSO, Director of the Centre for research in international health from Barcelona (CRESIB). Malaria Workshop

On Friday presented the latest advances in malaria research directed at the control and eradication of this disease in the “Malaria Day Workshop”, organized by the Campus for the development of drugs for diseases in countries in development of GlaxoSmithKline (DDW – GSK) and Medicines for Malaria Venture (MMV).

This meeting has become apparent that the intensification of research efforts is allowing progress in malaria control. The increased use of the tools available to control the vector of malaria (mosquito of the Anopheles species), such as mosquito nets and insecticides, already is translating in a reduction in the number of deaths from malaria, which coupled with the availability and implementation of a future and upcoming vaccine, are essential for progress in controlling this disease. However, to achieve the ultimate goal, i.e., passing control to the eradication of malaria, we depend on to a large extent the discovery of new drugs to treat it and break the cycle of infection in such a way that will gradually reduce the number of malaria cases until you reach zero, explained Dr. Tim Wells, director of MMV.

This “Malaria Day” has brought together basic and clinical researchers from Spain and Portugal, who have shared information about the mechanisms of action of the new drugs in development and advances occurring in the knowledge of the pathogen (Plasmodium species parasite). Likewise, it has been argued on the research strategy which must continue, given the enormous complexity of the cycle of the malaria parasite, and critical aspects on which have to move forward in the knowledge of the biology of the parasite, immunology, epidemiology, biological vectors and interactions with the human host. Difficult understanding of certain mechanisms currently constitutes an important impediment to the development of tools for the control, and ultimately, the eradication of malaria.

Dr. Pedro Alonso, director of the Center for research in international health from Barcelona (CRESIB, Hospital Clinic-Universitat de Barcelona), has emphasized during the plenary Conference, research plays a key role in the fight against malaria, both for its prevention and control, diagnosis and treatment. The objective of research in malaria has control of the disease as a first step, reducing morbidity and mortality, but the ultimate goal is to achieve the eradication or interruption of transmission. So far the research has focused on human malaria caused by Plasmodium falciparum, but Dr. Alonso says that it is essential to develop research into another large parasite causing human malaria, Plasmodium vivax.

The malaria parasite is a very complex organism, and the emergence of resistance to drugs antimalarial drug commonly used for the treatment of this disease lies also in its complexity. The lack of efficacy of available treatments makes essential the development of innovative therapeutic alternatives which are very effective and advance scientific knowledge to prevent the occurrence of resistance in the future.

In this regard, Dr. Nick Cammack, director of GSK DDW, explains that the primary objective of DDW is find effective compounds of easy administration by mouth, well tolerated, rapid action and appropriate treatments for few days. This new generation of antimalarial drugs, to be directed to the very broad sector of the world’s most economically depressed population, must be especially affordable and put them within reach of these populations are those most in need. DDW commitment is to maintain a continuous flow of projects in r & d leading to drugs to be usable by the public health agency to control in the first instance and then eradicate this disease.

Public-private partnership

Dr. Tim Wells, director of the MMV, explained that “to achieve this new generation of treatments need new discoveries that can only be achieved with collaboration between the public academic field and the pharmaceutical industry.” Both actors are essential to achieve the proposed objectives. Access to the patient and the basic science are in hospitals and universities, respectively and the science, technology and knowledge that transform these ideas into new drugs are pharmaceutical companies. “So we are proud to have been working with GSK here, in three Cantos, during eight years in the development of a collection of new research projects that will come from new drugs which will contribute to the eradication of malaria”.

For its part, Prof. Virgilio do Rosario, of the Institute of hygiene and Tropical Medicine of the Nova University of Lisbon and co-organiser of the Iberian platform of Malaria, stands out as an intensified efforts to control this devastating disease, but that progress years ago do not always apply today and that malaria can be reemergiendo in countries where already considered eradicated.

Thus, Prof. do Rosario draws attention to the great work being done by scientists and researchers (only in Spain and Portugal there are 34 research groups which collaborate with each other) and on new technologies that are being implemented to improve the knowledge of the relationship between the pathogen and the host.

Likewise, explains Prof. do Rosario there are certain aspects of difficult research by the complexity of the cycle of the parasite and that differences in levels of prevalence and incidence of disease among the different regions of the world, involves approaches and different strategies which will further complicate the work.

In this line, Prof. do Rosario insists that there are other important factors to achieve the desired success as well as the research: have good health infrastructure, trained personnel and the commitment of Governments and affected communities. Given this scenario, most likely in the coming years to increase the interaction between science and society.

GlaxoSmithKline

GlaxoSmithKline (GSK) is committed to searching for solutions to alleviate the effects of malaria. In this regard, in addition to working on the development of a vaccine, it has a Campus for the development of drugs for diseases in developing countries (DDW) in Tres Cantos (Madrid) in which work in the discovery of new drugs for diseases that disproportionately affect the economically weaker populations. The research model which GSK remains in the center of Tres Cantos is based on collaboration with public and private, national and international institutions, among which are the Medicines for Malaria Venture and the Centro de investigación en Barcelona international health (CRESIB, Hospital Clínic-Universitat de Barcelona).

You medicines for Malaria Venture

You medicines for Malaria Venture (MMV) is a non-profit created in 1999 and dedicated to the discovery, development and provision of safe, effective and affordable antimalarials through a series of partnerships between the public and private sectors.

MMV aims to heal and protect the millions of people exposed to malaria through effective and affordable medicines and future, to eradicate this terrible disease.

Currently, MMV manages the largest portfolio of research projects and development of ever assembled antimalarial drugs, nearly 60 projects in 44 countries, in collaboration with more than 130 partners from the pharmaceutical industry, academia and the malaria-endemic countries.

Read More

Viajarsano.com, website of reference before you leave home.

Viajarsano.com, web reference before you leave travel.

This Web site, that counts with the collaboration of GlaxoSmithKline, has spent eight years offering information on travel and health.

-Provides specific recommendations country by country, a complete list of diseases, vaccination tips and a guide for the traveller

Madrid, July 2010.- the Spanish society of Tropical Medicine and Health International (SEMETS), with the technical of GlaxoSmithKline (GSK) collaboration, offers travelers rigorous information mainly concerning health and travel through the Viajarsano web of free access for the general public.

www.viajarsano.com is the website of reference for the traveller, especially at this time that increase international transfers. This portal informs of sanitary precautions before embarking on a trip, also offered practical advice on vaccinations, disease, and specific recommendations depending on the country of destination.

According to Dr. Rogelio López-Velez, director of the initiative and responsibility for the unit of Tropical Medicine at the Hospital Ramón y Cajal, Madrid, the website is structured in such a way that allows easy and comfortable access and offers a very complete information for those interested.

“ Is possible to report accurately – explains the doctor López-Vélez – of the necessary precautions when it comes to embark on a journey. The traveller needs individualized advice because the epidemiology changes. Naturally, the chances of contracting a disease vary greatly according to the conditions of travel and the peculiarities of the traveller. The risk factors most supported in the type of trip are rucksack and adventure routes, stay in rural areas away from the usual tourist circuits, the journey over four weeks and having as destination the Sub-Saharan Africa, especially in the rainy season ”.

The website was the first characteristics to March Spanish in the year 2002 and its value has been increasing with various updates. Recently has been a review in depth and have expanded the content, including information about new diseases and upgrading specific recommendations about precautions to take in each country.

Vaccination has a decisive impact on the prevention of infectious diseases. One of the most useful information is the location of the vaccination centres in each autonomous community, which is essential to go before undertaking any international travel, as well as information on recommended vaccinations depending on the country you’re going to visit and the planned risk such as hepatitis A virus and vaccines mandatory in certain circumstances and (b), the difteria-tétanos or typhoid fever, among others.

Malaria or malaria for its wide distribution is a disease that requires a specific section that provides detailed information on how it is produced and its consequences, how to avoid, when to suspect, how to diagnose and how to deal with her.

Passenger guide

The website includes an ‘ Traveler Guide ’ with General advice on specific issues such as rules for traveling with children, during the pregnancy, if it’s older people or when you have a chronic disease.

How to protect themselves from the Sun and heat, protection against arthropod or acclimatization to high altitude are other sections of this guide. This is not to mention other aspects such as the food risks and by water, economy class syndrome or jet lag.

Moreover, even if trip is over and now we are back at home there which ‘ lower our guard at all ’ that some tropical diseases are not manifest immediately.

Another issue that should not be forgotten when traveling is the preparation of a first aid kit with medical supplies. Www.viajarsano.com recommends include basic medicines to treat common ailments, for first aid items and any special product may require the traveler personally.

Medications that need prescription must be accompanied by a report signed by a physician which expose the traveller needs that medication for his personal treatment based on their diagnosis.

Also please carry medicines in hand baggage to avoid possible losses during the trip but more desirable would be duplicate equipment in checked baggage.

SEMETS

www.viajarsano.com is part of the external coverage of the Spanish society of Tropical Medicine and international health (SEMETS), a multidisciplinary medical society composed of more than 400 specialists dealing, inter alia, the issue of the medicine of the traveler from points of view as diverse as basic researchmedical attention and international cooperation.

Read More

GlaxoSmithKline is the pharmaceutical company committed to facilitating access to medicines in developing countries, according to “Access to Medicine Index”.

GlaxoSmithKline is the pharmaceutical company committed to facilitating access to medicines in developing countries, according to “ Access to Medicine Index ”.

Madrid, July 2010.- GlaxoSmithKline (GSK) has been singled out by the “ Access to Medicine Index ” as the pharmaceutical company, responsible and committed sector in humanitarian work by sending continuous medicines to countries in developing. This prestigious ranking, which analyzes the efforts of the leading companies in this sector, has been located at GSK in the first place in the ranking.

The authors of this report, the second carried out after the first edition published in 2008, have pointed out that the pharmaceutical industry has evolved in these two years in the number of initiatives in CSR. Thus, include areas such as research and development and more equitable and accessible pricing.

The co-founder of this ranking, Wim Leereveld, stressed the long way to go has the pharmaceutical industry in the world. For its part, Carissa Etienne, Assistant Director-general of the World Health Organization (WHO), has been added to the “ Access to Medicine Index ” in addition to assess industry individually promoted access to essential medicines.

In the 2010 edition of “ Access to Medicine Index ” highlights the fact that six of the ten companies with best score are European and four American.

The above ranking, which can be consulted on the website http://www.accesstomedicineindex.org, was created by the Dutch Foundation “ Access to Medicine ” in collaboration with the consultant “ RiksMetrics ”, specializing in corporate social responsibility (CSR).

GlaxoSmithKline – one of the leading companies in research-based pharmaceutical and health care is committed to the improvement of the quality of life of people doing that to live more and better.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips